{
  "url": "https://www.law.cornell.edu/regulations/new-york/14-NYCRR-800.4",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 800.4 - Definitions",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 800.4 - Definitions\n\nState Regulations\n\nThe following terms are defined for purposes of all Parts of\n\nChapter XXI of this Title, unless a term is defined and indicated as applicable\nonly for purposes of a specific Part. (a) \"Addiction disorder\" means substance use\ndisorder as defined in this Part and/or gambling disorder as defined in this\n\nTitle and/or problem gambling as defined in this Title. (b) \"Addiction services\" means examination, evaluation, diagnosis, care, treatment, or rehabilitation of persons with\nsubstance use disorder, gambling disorder, or problem gambling and their\nfamilies or significant others. (c) \"Approved medication\" means any medication approved by state and federal\nauthorities for the treatment of substance use disorder. (d) \"Clinical staff\" is staff who provide\nservices directly to patients as prescribed in a treatment/recovery plan; clinical staff includes licensed medical staff, credentialed or licensed staff, non-credentialed staff, and student interns. (e) \"Commissioner\" means the Commissioner of\nthe Office of Addiction Services and Supports unless otherwise\nindicated. (f) \"Diagnosis\" for\npurposes of admission, treatment and level of care transition planning\n(discharge planning) means the identification criteria contained in the most\ncurrent editions of both the International Classification of Diseases, and the\n\nDiagnostic and Statistical Manual. (g) \"Full Opioid agonist\" means\nmethadone. (h) \"Medical Director\". (1)\n\nEach program must have a physician\ndesignated by the program governing authority to be the medical director. The\nmedical director shall be a physician licensed and currently registered as such\nby the New York State Education Department and shall have at least one year of\neducation, training, and/or experience in substance use disorder services. The\nmedical director is a physician who has overall responsibility for the\nfollowing (this overall responsibility may not be delegated): (i) medical services provided by the\nprogram; (ii)\noversight of the\ndevelopment and revision of policies, procedures and ongoing training for\nmatters including, but not limited to, routine medical care, specialized\nservices, specialized medications, medical and psychiatric emergency care, screening for, and reporting of, transmissible infections and infection in\naccordance with law, public health education including prevention and harm\nreduction; (iii)\ncollaborative\nsupervision with the program director of non-medical staff in the provision of\nsubstance use disorder services; (iv)\nsupervision of medical staff in the\nperformance of medical services; (v) assisting in the development of necessary\nreferral and linkage relationships with other institutions and agencies\nincluding, but not limited to, general or specialty hospitals and nursing\nhomes, health-related facilities, home health agencies, hospital outpatient\ndepartments, diagnostic and treatment facilities, laboratories and related\nresources; (vi)\nensuring program\ncompliance with all federal, state and local laws and\nregulations. (2)\n\nAll\nmedical directors, whether full-time or part-time, other than medical directors\nin place as of the effective date of this regulation, must hold a board\ncertification in addiction medicine from a certifying entity appropriate to\ntheir primary or specialty board certification. Physicians may be hired as\nprobationary medical directors if not so certified but must obtain\ncertification within four (4) years of being hired. In addition, the medical\ndirector must have a federal DATA 2000 waiver to prescribe\nbuprenorphine. (3)\n\nThe medical\ndirector may serve as medical director of more than one program certified by\nthe Office. (i) \"Medical\nstaff\" means physicians, nurse practitioners, registered physician assistants, and registered nurses licensed and certified by the State Education Department\npracticing within the scope of, and in accordance with, the terms and\nconditions of such licenses and certifications, and working with, or under the\nsupervision of a physician, or other medical professional if required by\nlaw. (j) \"Medication for addiction\ntreatment\" (MAT) means treatment of substance use disorder i.e., substance use\ndisorder and concomitant conditions with medications requiring a prescription\nor order from an authorized prescribing professional. (k) \"Multi-disciplinary team\" means a team of\nhealth professional staff including, at a minimum, one medical staff member\n(where applicable) as defined in this section, one credentialed alcoholism and\nsubstance abuse counselor (CASAC) and one other staff member who is a qualified\nhealth professional as defined in this section in a discipline other than\nalcohol and substance use disorder counseling. If the treatment service has a\ngambling designation on their operating certificate, the multi-disciplinary\nteam must include Qualified Problem Gambling Professional (QPGP), consistent\nwith this Chapter. (l) \"Naloxone\nemergency overdose prevention kit\" means a kit as prescribed or distributed\npursuant to state law and is used to reverse an opioid overdose. (m) \"Office\" or \"OASAS\" means the New York\n\nState Office of Addiction Services and Supports. (n) \"Opioid agonist\" means methadone or\nbuprenorphine and/or buprenorphine/naloxone, or any other agonist medication\nthat may be approved by the federal or state government for the treatment of\nopioid use disorder. (o) \"Opioid\nantagonist\" for purposes of substance use disorder treatment medication means\nnaltrexone. Opioid antagonist for purposes of overdose prevention medication\nmeans naloxone. (p) \"Partial Opioid\nagonist\" means buprenorphine and/or buprenorphine/naloxone. (q) \"Peer advocate\" is a Certified Recovery\n\nPeer Advocate (CRPA) who holds a certification from a certifying authority\nrecognized by the Commissioner. (r) \"Prescribing professional\" is any medical professional appropriately licensed\nunder New York State law and registered under federal law to prescribe approved\nmedications. (s) \"Program\" means a\nlocation wherein a provider is authorized to provide addiction\nservices. (t) \"Provider\" means an\nindividual, association, partnership, corporation, public or private agency\ngoverning authority, as governing authority is defined in this Part, other than\nan agency or department of the state, which provides addiction services via one\nor more Office certified, funded or otherwise authorized program. (u) Qualified Health Professional\" means any\nof the professionals listed below, who are in good standing with the\nappropriate licensing or certifying authority, as applicable, with a minimum of\none year of experience or satisfactory completion of a training program in the\ntreatment of addiction: (1)\na credentialed\nalcoholism and substance abuse counselor (CASAC) who has a current valid\ncredential issued by the Office, or a comparable credential, certificate or\nlicense from another recognized certifying body as determined by the\n\nOffice; (2)\na counselor certified by\nand currently registered as such with the National Board for Certified\n\nCounselors; (3)\na rehabilitation\ncounselor certified by the Commission of Rehabilitation Counselor\n\nCertification; (4)\na therapeutic\nrecreation therapist certified by the National Council on Therapeutic\n\nRecreation or the American Therapeutic Recreation Association; or a person who\nholds a baccalaureate degree in a field allied to therapeutic recreation and, either before or after receiving such degree, has five years of full-time, paid\nwork experience in an activities program in a health care setting; (5)\na professional licensed and currently\nregistered as such by the New York State Education Department to include: (i) a physician who has received a doctor of\nmedicine (M.D.) or doctor of osteopathy (D.O.) degree; (ii)\na physician assistant (PA); (iii)\na certified nurse practitioner\n(NP); (iv). a registered nurse\n(RN); (v) a psychologist; (vi)\nan occupational therapist; (vii)\na social worker (LMSW; LCSW), including\nan individual with a Limited Permit Licensed Master Social Worker (LP-LMSW)\nonly if such person has a permit which designates the OASAS-certified program\nas the employer and is under the general supervision of a LMSW or a LCSW; and\n(viii)\na mental health\npractitioner including: a licensed mental health counselor (LMHC), a marriage\nand family therapist (LMFT), a creative arts therapist (LCAT), and licensed\npsychoanalyst; and any mental health practitioner with a Limited\n\nPermit. (v) \"Quality improvement\" means an ongoing process by which an addiction service\nsystematically assesses the adequacy and appropriateness of the addiction\ntreatment services provided to patients and provides recommendations for\nimprovement. (w) \"Significant\nother\" is an individual who is admitted to treatment and manifests\npsychological, behavioral and/or emotional effects arising from another\nperson's substance use disorder, regardless of whether the other individual is\nin treatment. A significant other must be determined to be able to participate\nactively in and benefit from the treatment process. (x) \"Governing authority\" means the provider\nof service or an entity that substantially controls or has the ability to\ncontrol substantially the provider of service. For the purpose of this Part, factors used to determine whether there is substantial control shall include, but are not limited to, the following: (1)\nthe right to appoint and remove directors or officers; (2)\nthe right to approve bylaws or articles\nof incorporation; (3)\nthe right to\napprove strategic or financial plans for a provider of service; or\n(4)\nthe right to approve operating or capital\nbudgets for a provider of service. (y) \"Student Intern\" means a person enrolled\nin a formal educational program which could lead to a degree, certification or\ncredential which may qualify that person as a Qualified Health\n\nProfessional. (z) \"Substance use\ndisorder\" means a group of cognitive, behavioral, and physiological symptoms\nindicating that an individual continues using substances despite significant\nsubstance-related physical, psychological and social problems as determined\nthrough assessment and diagnosis using the most recent version of the DSM. Substance use disorder, or addiction, is a treatable, chronic medical\ncondition. Substance use disorder treatment shall include alcoholism, alcohol\nabuse, substance abuse, substance dependence, chemical dependence, chemical\nabuse and/or chemical dependence. (aa)\n\"Substance use disorder services\" or\n\"chemical dependence services\" shall mean and include examination, evaluation, diagnosis, care, treatment, or rehabilitation of persons with substance use\ndisorders and their families or significant others. (bb)\n\"Utilization review\" means a process by\nwhich a service systematically monitors the appropriateness of admissions, the\nneed for continued stay, and the necessity for an alternative level of\ncare. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 14\nยง\n800.4\n\nAdopted\n\nNew\n\nYork State Register December 9, 2015/Volume XXXVII, Issue 49, eff. 11/20/2015\n\nAmended\n\nNew\n\nYork State Register May 29, 2019/Volume XLI, Issue 22, eff. 5/29/2019\n\nAmended\n\nNew\n\nYork State Register February 16, 2022/Volume XLIV, Issue 07, eff. 2/16/2022\n\nAmended\n\nNew\n\nYork State Register September 14, 2022/Volume XLIV, Issue 37, eff. 10/1/2022\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 2802
}